Next-generation sequencing powered liquid biopsies can be an effective way to detect residual cancer after primary treatment.

Investigating how mutations in tumors alter DNA’s 3D structure—and subsequently, regulatory sequences called enhancers—can ...

A deep-learning model trained on human data reveals that promoter mutations may explain a significant portion of unsolved ...